Celladon Gains $21.8M
La Jolla-based Celladon, a developer of treatments for heart failure and other cardiovascular diseases, has raised $21.8M out of a $24.6M funding round, according to a filing from the firm today. Details on the new funding round were not disclosed by the company. The firm now lists Enterprise Partners, Venrock, and Johnson & Johnson Development Corporation as investors in the company.
posted on Friday, September 11, 2009 (Link to more information)

Related companies:

Related stories:
> Celladon Files For IPO
> Celladon Raises $30M
> Celladon Gets $43M For Heart Failure Treatments
> Celladon Gets $53M In Funding
> AltheaDx Names CFO Home